Atlas Trials

Real World Evidence of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C in the Russian Federation

Clinical trial NCT03868163 · COMPLETED

Trial details

NCT number
NCT03868163
Sponsor
AbbVie
Status
COMPLETED
Study type
OBSERVATIONAL
Chronic Hepatitis C (CHC)
Start date
2019-02-28
Primary completion
2020-09-04
Enrollment
161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.